JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Search results for: 'deaf+texas+and+benchmarking'

Search results for: 'deaf+texas+and+benchmarking'

Did you mean: deal terms and benchmarking

Viral Vector Collaboration and Licensing Deals 2016-2024
November 2024

$3,995.00

Add to Wish List Add to Compare

Viral Vector Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More
Artificial Intelligence (AI) Collaboration and Licensing Deals 2019-2024
November 2024

$3,995.00

Add to Wish List Add to Compare

Artificial Intelligence (AI) Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2024
Learn More
Cardiovascular Collaboration and Licensing Deals 2016-2024
October 2024

$3,995.00

Add to Wish List Add to Compare

Cardiovascular Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More
Companion Diagnostic Collaboration and Licensing Deals 2010-2024
November 2024

$3,995.00

Add to Wish List Add to Compare

Companion Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2010 to 2024
Learn More
Monoclonal Antibody Collaboration and Licensing Deals 2019-2024
May 2024

$3,995.00

Add to Wish List Add to Compare

Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More
Antibody Collaboration and Licensing Deals 2019-2024
November 2024

$3,995.00

Add to Wish List Add to Compare

Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2024
Learn More
Genomic Collaboration and Licensing Deals 2018-2024
November 2024

$3,995.00

Add to Wish List Add to Compare

Genomics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2018 to 2024
Learn More
In Vitro Diagnostic Collaboration and Licensing Deals 2016-2024
November 2024

$3,995.00

Add to Wish List Add to Compare

In Vitro Diagnostic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2024
November 2024

$3,995.00

Add to Wish List Add to Compare

Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More
Co-development Deals in Pharmaceuticals and Biotechnology 2016-2024
September 2024

$3,995.00

Add to Wish List Add to Compare

Co-development Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More